4Cozma A, Orasan O, Sampelean D, et al.Endothelial dysfunction in metabolic syndrome [J]. RomJ Intern Med, 2009, 47: 133-140.
5YangT, Chu CH, Hsu CH, et al. Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study [J]. Nephrology, 2012, 17: 532-538.
6Bonora E, Kiechl S, Zoppini G, et al. Impact of reference category and number of traits in the cluster on risk of coronary heart disease in metabolic syndrome: prospective data from the Bruneck study [J]. MetabSyndrRelat Disord, 2011, 9: 313-318.
7Bokura H, Yamaguchi S, Iijima K, et al. Metabolic syndrome is associated with silent ischemic brain lesions[J]. Stroke, 2008, 39 : 1607-1609.
8Park K,Yasuda N, Toyonaga S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects[J]. Neurology, 2007, 69, 974-978.
9Kim MH, Moon JS, Park SY, et al. Different risk factor profiles between silent brain infarction and symptomatic lacunar infarction[J]. Eur Neurol, 2011, 65:250-256.
10Choi HS,Cho YM, Kang JH, et al. Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans[J]. Clin Endocrinol, 2009,71 : 184-188.
